Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| PROTEIN DESIGN LABS INC/DE | 40,083 | reported | 04 Nov 2009 | tx 63+107,983−48,000 |
| BIOMARIN PHARMACEUTICAL INC | 35,000 | reported | 08 Mar 2010 | tx 44+197,500−167,000 |
| NPS PHARMACEUTICALS INC | 35,000 | reported | 23 May 2007 | tx 25+40,543−50,800 |
| SAVIENT PHARMACEUTICALS INC | 17,388 | reported | 08 Jun 2010 | tx 37+87,446−52,345 |
| IONIS PHARMACEUTICALS INC | 11,014 | reported | 01 May 2026 | tx 351+798,451−731,622 |
| GUILFORD PHARMACEUTICALS INC | 7,500 | reported | 05 May 2004 | tx 2+15,000 |
| GENAISSANCE PHARMACEUTICALS INC | 5,000 | reported | 01 Oct 2003 | tx 5+45,000 |
| CLINICAL DATA INC | 1,000 | reported | 11 Oct 2006 | tx 2−5,971 |
| OSI PHARMACEUTICALS INC | 0 | reported | 08 Jun 2010 | tx 62+75,750−78,750 |
| AKCEA THERAPEUTICS, INC. | 0 | reported | 12 Oct 2020 | tx 3+79,400−26,400 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 01 May 2026 | EXERCISE | IONIS PHARMACEUTICALS INC | 10,111 | 47.11 USD | 10b5-1 |
| 01 May 2026 | SALE | IONIS PHARMACEUTICALS INC | 8,680 | 73.35 USD | 10b5-1 |
| 01 May 2026 | SALE | IONIS PHARMACEUTICALS INC | 1,431 | 74.45 USD | 10b5-1 |
| 01 May 2026 | EXERCISE | IONIS PHARMACEUTICALS INC | 10,111 | 0.00 USD | 10b5-1deriv |
| 03 Mar 2026 | EXERCISE | IONIS PHARMACEUTICALS INC | 4,000 | 42.88 USD | |
| 03 Mar 2026 | SALE | IONIS PHARMACEUTICALS INC | 13,526 | 79.17 USD | |
| 03 Mar 2026 | SALE | IONIS PHARMACEUTICALS INC | 6,794 | 80.00 USD | |
| 03 Mar 2026 | EXERCISE | IONIS PHARMACEUTICALS INC | 12,000 | 40.05 USD | |
| 03 Mar 2026 | SALE | IONIS PHARMACEUTICALS INC | 1,012 | 80.82 USD | |
| 03 Mar 2026 | EXERCISE | IONIS PHARMACEUTICALS INC | 4,000 | 0.00 USD | deriv |
| 03 Mar 2026 | EXERCISE | IONIS PHARMACEUTICALS INC | 12,000 | 0.00 USD | deriv |
| 25 Nov 2025 | SALE | IONIS PHARMACEUTICALS INC | 4,000 | 80.00 USD | |
| 25 Nov 2025 | EXERCISE | IONIS PHARMACEUTICALS INC | 4,000 | 0.00 USD | |
| 25 Nov 2025 | SALE | IONIS PHARMACEUTICALS INC | 4,000 | 80.00 USD | |
| 25 Nov 2025 | EXERCISE | IONIS PHARMACEUTICALS INC | 4,000 | 0.00 USD | |
| 25 Nov 2025 | SALE | IONIS PHARMACEUTICALS INC | 4,000 | 80.00 USD | |
| 25 Nov 2025 | EXERCISE | IONIS PHARMACEUTICALS INC | 4,000 | 0.00 USD | |
| 25 Nov 2025 | EXERCISE | IONIS PHARMACEUTICALS INC | 4,000 | 0.00 USD | deriv |
| 25 Nov 2025 | EXERCISE | IONIS PHARMACEUTICALS INC | 4,000 | 0.00 USD | deriv |
| 25 Nov 2025 | EXERCISE | IONIS PHARMACEUTICALS INC | 4,000 | 0.00 USD | deriv |
| 03 Sept 2025 | EXERCISE | IONIS PHARMACEUTICALS INC | 12,000 | 0.00 USD | |
| 03 Sept 2025 | EXERCISE | IONIS PHARMACEUTICALS INC | 16,000 | 0.00 USD | |
| 03 Sept 2025 | SALE | IONIS PHARMACEUTICALS INC | 28,000 | 60.00 USD | |
| 03 Sept 2025 | EXERCISE | IONIS PHARMACEUTICALS INC | 16,000 | 0.00 USD | deriv |
| 03 Sept 2025 | EXERCISE | IONIS PHARMACEUTICALS INC | 12,000 | 0.00 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 03 Jan 2006.